PsyRx

PsyRx is at the forefront of innovation, actively participating in the development of breakthrough antidepressant drugs. This novel medication combines microdoses of ibogaine with proven selective serotonin reuptake inhibitors (SSRIs), aiming to enhance efficacy while minimizing onset time and potential side effects.